SHL Telemedicine (NASDAQ:SHLT) Trading Down 2.7% – What’s Next?

Shares of SHL Telemedicine Ltd. (NASDAQ:SHLTGet Free Report) fell 2.7% during trading on Wednesday . The stock traded as low as $2.22 and last traded at $2.36. 1,120 shares changed hands during trading, a decline of 71% from the average session volume of 3,843 shares. The stock had previously closed at $2.42.

SHL Telemedicine Stock Performance

The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.98 and a current ratio of 2.17. The business’s 50 day moving average is $2.70 and its two-hundred day moving average is $3.00.

Hedge Funds Weigh In On SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Value Base Ltd. purchased a new position in SHL Telemedicine Ltd. (NASDAQ:SHLTFree Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 941,923 shares of the company’s stock, valued at approximately $2,496,000. SHL Telemedicine makes up about 1.5% of Value Base Ltd.’s investment portfolio, making the stock its 6th largest holding. Value Base Ltd. owned 5.75% of SHL Telemedicine as of its most recent SEC filing. Hedge funds and other institutional investors own 20.11% of the company’s stock.

About SHL Telemedicine

(Get Free Report)

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.

Further Reading

Receive News & Ratings for SHL Telemedicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SHL Telemedicine and related companies with MarketBeat.com's FREE daily email newsletter.